Dr. Sarah D. Shepherd, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 25 June St, Sanford, ME 04073 Phone: 928-757-2101 |
Marshall T Chamberlin, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 25 June St, Sanford, ME 04073 Phone: 207-324-4310 |
Scott Hamilton, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 25 June St, Sanford, ME 04073 Phone: 207-490-7433 |
Dr. Lare Huber, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 25 June St, Sanford, ME 04073 Phone: 207-324-4310 |
Donald Lyon, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 25 June St, Sanford, ME 04073 Phone: 207-324-4310 |
Dr. Andrew Powell, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 25 June St, Sanford, ME 04073 Phone: 207-490-7450 |
News Archive
A new study by the Australian Medical Association (AMA) has found close to half of Australia's junior doctors think their heavy workload could compromise patient care.
IsilonĀ® Systems today announced that Mount Sinai School of Medicine's Genomics Institute and Department of Genetics and Genomic Sciences has deployed Isilon scale-out NAS as the primary repository for its next-generation DNA sequencing and analysis workflow.
In the largest single-center study of patients with rheumatologic diseases who were prescribed modern cancer immunotherapy with what are called immune checkpoint inhibitors, only a minority of patients experienced a flare of their rheumatologic disease or immune-related side effects.
A drug widely used to treat seizures and anxiety appears to be an effective treatment for restless legs syndrome (RLS) and helps people with the disorder get a better night's sleep, according to a study that will be presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle.
A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the decade-long clinical trials.
› Verified 2 days ago